IRIS
Modica, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.594
EU - Europa 2.187
NA - Nord America 1.789
SA - Sud America 434
AF - Africa 86
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 8.098
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.885
US - Stati Uniti d'America 1.702
RU - Federazione Russa 1.232
CN - Cina 966
BR - Brasile 345
IT - Italia 318
HK - Hong Kong 285
VN - Vietnam 197
DE - Germania 167
NL - Olanda 89
KR - Corea 88
GB - Regno Unito 77
FI - Finlandia 72
FR - Francia 70
IN - India 60
CA - Canada 47
CI - Costa d'Avorio 38
AR - Argentina 37
SE - Svezia 32
UA - Ucraina 29
MX - Messico 27
ZA - Sudafrica 24
PL - Polonia 23
BD - Bangladesh 16
CO - Colombia 16
ES - Italia 16
ID - Indonesia 15
IE - Irlanda 15
JP - Giappone 15
AT - Austria 14
EC - Ecuador 14
TR - Turchia 10
IQ - Iraq 9
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
UZ - Uzbekistan 7
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
CL - Cile 5
VE - Venezuela 5
AU - Australia 4
PE - Perù 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
UY - Uruguay 3
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
CR - Costa Rica 2
DM - Dominica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GI - Gibilterra 2
LY - Libia 2
MD - Moldavia 2
MZ - Mozambico 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
NI - Nicaragua 1
PW - Palau 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 8.098
Salva come PNG Salva come JPEG
Città #
Singapore 987
Hefei 485
Moscow 333
Hong Kong 285
Beijing 247
Ashburn 227
Chandler 183
Santa Clara 151
Seoul 87
Naples 84
Los Angeles 83
Amsterdam 71
Ho Chi Minh City 71
Munich 59
Hanoi 45
Redondo Beach 43
Buffalo 36
Seattle 35
Helsinki 34
São Paulo 33
Kochi 32
The Dalles 31
Frankfurt am Main 29
New York 29
Turku 24
Milan 23
Millbury 23
Boston 22
Düsseldorf 22
Dallas 20
Des Moines 20
Rome 20
London 19
Napoli 19
Brooklyn 17
Jacksonville 17
Orem 17
Mexico City 16
Rio de Janeiro 16
Warsaw 16
Chicago 15
Falkenstein 15
Nanjing 15
Ottawa 15
Houston 14
Lawrence 14
Stockholm 14
Chennai 13
Denver 13
Poplar 13
Princeton 13
Tokyo 13
Dong Ket 12
Nuremberg 12
Washington 12
Wilmington 12
Johannesburg 11
Toronto 11
Phoenix 10
Portici 10
Portsmouth 10
Lappeenranta 9
Roubaix 9
Brasília 8
San Francisco 8
Afragola 7
Bexley 7
Biên Hòa 7
Buenos Aires 7
Campinas 7
Kronberg 7
Montreal 7
Nanchang 7
Porto Alegre 7
Vienna 7
Atlanta 6
Baku 6
Brussels 6
Dhaka 6
Guayaquil 6
Manchester 6
Phủ Lý 6
Salt Lake City 6
Caxias do Sul 5
Da Nang 5
Dublin 5
Haiphong 5
Hải Dương 5
Lauterbourg 5
Ninh Bình 5
Paris 5
Rochdale 5
Tashkent 5
Uberlândia 5
Ankara 4
Bari 4
Belo Horizonte 4
Bogotá 4
Bắc Giang 4
Cervinara 4
Totale 4.509
Salva come PNG Salva come JPEG
Nome #
GLP-1: benefits beyond pancreas. 129
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 129
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 128
Hepatic arterial embolization in patients with neuroendocrine tumors. 126
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 124
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 120
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 120
Quality of life in patients with neuroendocrine neoplasms: The role of severity, clinical heterogeneity and resilience 120
Pituitary function and morphology in Fabry disease. 117
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 117
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 114
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 112
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 111
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 111
A rare rarity: Neuroendocrine tumor of the esophagus 109
Open issues on G3 neuroendocrine neoplasms: Back to the future 107
Nutrition and neuroendocrine tumors: An update of the literature. 107
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 106
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 105
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 102
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 101
Neuroendocrine Neoplasms 99
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 99
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 98
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 96
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 95
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 95
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 94
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 93
The safety of available treatments options for neuroendocrine tumors 93
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 91
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 91
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons 90
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 90
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms 90
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 88
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 88
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 88
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 87
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 86
Prognostic significance of laterality in lung neuroendocrine tumors 86
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 86
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 86
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 86
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 85
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 85
Parathyroid diseases and metabolic syndrome 84
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC) 84
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 84
PRRT: identikit of the perfect patient 82
Sunitinib nei feocromocitomi e paragangliomi 82
Neuroendocrine Tumors and Immune System 82
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 81
Neuroendocrine Tumors and Survival Rates in Multiple Endocrine Neoplasia Type 1 Patients: Impact of Gender Difference 81
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 81
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 79
Selpercatinib e carcinoma midollare della tiroide 79
Erratum to: GLP-1: Benefits beyond pancreas 78
Gestione integrata del tumore della prostata: il ruolo dell’endocrinologo 77
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 77
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 76
Nuove strategie terapeutiche per il trattamento dei NET 76
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 75
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms 75
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 75
Corrigendum to: Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 74
Endocrine Pathology 73
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 72
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 71
Gender Differences in Lung Neuroendocrine Tumors: A Single-Center Experience 70
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 70
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 69
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 68
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 68
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 67
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 67
Cardiac mechanical synchrony couples with myocardial sympathetic innervation. A retrospective study with novel echocardiographic assessment in patients with 123I-mIBG imaging 66
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays 65
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 62
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 61
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 60
Editorial: Neuroendocrine tumors: the road to precision medicine 58
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) 57
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 56
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 56
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? 55
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 54
Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumors 53
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 51
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial 47
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia 46
Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker? 46
Carcinoma showing thymus-like differentiation (CASTLE): a case report 46
Telling science and Innovation. Rare plat net 44
Gender perspective in Lung Neuroendocrine Tumors: a critical review 43
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 43
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? 42
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists 42
Gender impact on pancreatic neuroendocrine neoplasm (PanNEN) prognosis according to survival nomograms 37
Metastasi ossee nei tumori neuroendocrini: presentazione clinica e terapia 37
Totale 8.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 13 9 1 7 2 6 13
2021/2022211 2 0 25 3 5 14 1 6 16 15 62 62
2022/2023485 30 57 14 39 50 40 54 32 47 79 41 2
2023/2024510 20 65 51 48 40 67 17 83 3 16 68 32
2024/20252.992 107 82 25 34 103 210 324 236 170 313 1.109 279
2025/20263.817 599 752 667 638 1.020 141 0 0 0 0 0 0
Totale 8.250